MedTrace Logo

Dyslipidemia and Diabetic Retinopathy

NCT03403283 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2024-05-21

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if the reparative cells of blood vessels called endothelial progenitor cells(EPC) are defective in people with diabetes.

Conditions

Interventions

OTHER

15 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic Retinopathy

OTHER

Healthy Controls 15 age matched control subjects

Sponsors & Collaborators

  • National Eye Institute (NEI)

    collaborator NIH

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Maria B Grant, MD · University of Alabama at Birmingham

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2023-04-30
Completion
2023-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03403283 on ClinicalTrials.gov